The challenge of neovascular glaucoma and the role of Central Corneal Thickness

St. Kostova

doi:10.14748/bro.v0i2.4536

The challenge of neovascular glaucoma and the role of Central Corneal Thickness

St. Kostova

Abstract

Neovascular glaucoma (NVG) is a potentially devastating glaucoma, where delayed diagnosis or poor management can result in complete loss of vision or, quite possibly, loss of the globe itself. Early diagnosis of the disease, followed by immediate and aggressive treatment, is imperative. In managing NVG, it is essential to treat both the elevated intraocular pressure (IOP) and the underlying cause of the disease. Тhere are observed 20 eyes of 20 patients with NVG and discussed the role of Central Corneal Thickness.

Keywords

neovascular glaucoma; diagnosis; treatment; Central corneal thickness

Full Text

References

Brandt JD, Beiser JA, Kass MA, Gordon MO. Central corneal thickness in the ocular hypertension treatment study (OHTS). Ophthalmology 2001;108:1779-88.

Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. Surv Ophthalmol 2000;44:367-408.

European Glaucoma Prevention Study (EGPS) Group. Predictive factors for open-angle glaucoma among patients with ocularhypertension in the European glaucoma prevention study. Ophthalmology 2007;114:3-9.

Gordon MO, Beiser JA, Brandt JD, et al. Th e ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:714-20; discussion 829-30.

Goldmann H, Schmidt T. Applanation tonometry. Ophthalmo-logica 1957;134:221-42.

Havens SJ, Gulati V. Neovascular Glaucoma. Dev Ophthalmol. 2015. 55:196-204.

La Rosa FA, Gross RL, Orengo-Nania S. Central corneal thickness of Caucasians and African-Americans in glaucomatous and nonglaucomatous populations. Arch Ophthalmol 2001;119:23-27.

Leszczynski R, Domanksi R, Forminksa-Kapuscik M, et al. Contact transscleral cyclophotocoagulation in the treatment of neovascular glaucoma: a fi ve-year follow-up. Med Sci Monit. 2009;15(3):BR84-7.

Moraczewski AL, Lee RK, Palmberg PF, et al. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab. Br J Ophthalmol. 2009;93:589-593.

Nemesure B, Wu SY, Hennis A, Leske MC for the Barbados Eye Study G. Corneal thickness and intraocular pressure in the Barbados Eye Studies. Arch Ophthalmol 2003;121:240-4.

Pokroy R, Greenwald Y, Pollack A, et al. Visual loss after transscleral diode laser cyclophotocoagulation for primary open-angle and neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2008;39(1):22-9

Shimmyo M, Ross AJ, Moy A, Mostafavi R. Intraocular pressure, Goldmann applanation tension, corneal thickness, and corneal curvature in Caucasians, Asians, Hispanics, and African-Americans. Am J Ophthalmol 2003;136:603-13.

Sommer A, Tielsch JM, Katz J, et al. Racial diff erences in the cause-specifi c prevalence of blindness in east Baltimore. N Engl J Med 1991;325:1412-7.

Takihara Y, Inatani M, Fukushima M, et al. Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. Am J Ophthalmol. 2009;147(5):912-8.

Tielsch JM, Sommer A, Katz J, et al. Racial variations in the prevalence of primary open-angle glaucoma: the Baltimore Eye Survey. JAMA 1991;266:369-74.

Tripathi RC, Li J, Tripathi BJ. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology. 1998 Feb. 105(2):232-7

Shields MB. Textbook of Glaucoma. 4th ed. 1998. 269-86.

Sivak-Callcott JA, O'Day DM, Gass JD, Tsai JC. Evidencebased recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. 2001 Oct. 108(10):1767- 76; quiz1777, 1800.

Weiss DI, Shaff er RN, Nehrenberg TR. Neovascular glaucoma complicating carotid-cavernous fi stula. Arch Ophthalmol. 1963;69:304. Allingham RR, Damji K, Freedman S, et al., editors. Shields` Textbook of Glaucoma. ed 5 Lippincott

Williams & 12Wilkins; Philadelphia: 2005. Glaucomas Associated with Disorders of the Retina, Vitreous, and Choroid; pp. 328-341.

DOI: http://dx.doi.org/10.14748/bro.v0i2.4536